Argus upgrades Bristol-Myers Squibb (NYSE: BMY) from Hold to Buy. Price target $32.

Argus analyst says, "We believe ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE